Harbin Medical University
122
15
26
27
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.6%
8 terminated/withdrawn out of 122 trials
77.1%
-9.4% vs industry average
8%
10 trials in Phase 3/4
7%
2 of 27 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (122)
Flow Patterns and Stent Thrombosis
Role: collaborator
Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers
Role: lead
Ischemic Stroke Nutrition Intervention Study
Role: lead
Time-Restricted Eating for Weight-Loss Maintenance
Role: lead
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
Role: lead
Retlirafusp Alfa Combined With Chemotherapy or Fuzuloparib for Triple-Negative Breast Cancer
Role: lead
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Role: lead
Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation
Role: lead
Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening
Role: lead
Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Role: lead
High-Protein Diet for Improving Alcoholic Fatty Liver Disease
Role: collaborator
Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study
Role: lead
A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China
Role: lead
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
Role: lead
Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer
Role: lead
Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
Role: lead
The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF
Role: lead
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
Role: lead
Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity
Role: collaborator
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
Role: lead